Skip Navigation

Cardiovascular Research 2003 58(2):423-434; doi:10.1016/S0008-6363(03)00253-0
© 2003 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bird, S.D.
Right arrow Articles by Mummery, C.L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bird, S.D.
Right arrow Articles by Mummery, C.L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2003, European Society of Cardiology

The human adult cardiomyocyte phenotype

S.D. Birda, P.A. Doevendansb,c,*, M.A. van Rooijena, A. Brutel de la Riviered, R.J. Hassinka,d, R. Passiera,b and C.L. Mummerya,b

aHubrecht Laboratory, Netherlands Institute for Developmental Biology, Utrecht, The Netherlands
bInteruniversity Cardiology Institute of the Netherlands, Utrecht, The Netherlands
cDepartment of Cardiology, Heart Lung Center, Utrecht, The Netherlands
dCardiothoracic Surgery, Heart Lung Center, Utrecht, The Netherlands

p.doevendans{at}hli.azu.nl

* Corresponding author. Present address: Department of Cardiology, HLCU, UMC, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. Tel.: +31-30-250-9111; fax: +31-30-254-2155.

Aim: Determination of the phenotype of adult human atrial and ventricular myocytes based on gene expression and morphology. Methods: Atrial and ventricular cardiomyocytes were obtained from patients undergoing cardiac surgery using a modified isolation procedure. Myocytes were isolated and cultured with or without serum. The relative cell attachment promoting efficiency of several reagents was evaluated and compared. Morphological changes during long-term culture were assessed with phase contrast microscopy, morphometric analysis and immunocytochemistry or RT-PCR of sarcomeric markers including {alpha}-actinin, myosin light chain-2 (MLC-2) and the adhesion molecule, cadherin. Results: The isolation method produced viable rod-shaped atrial (16.6±6.0%, mean±S.E.; n = 5) and ventricular cells (22.4±8.0%, mean±S.E.; n = 5) in addition to significant numbers of apoptotic and necrotic cells. Cell dedifferentiation was characterized by the loss of sarcomeric structure, condensation and extrusion of sarcomeric proteins. Cells cultured with low serum recovered and assumed a flattened, spread form with two distinct morphologies apparent. Type I cells were large, had extensive sarcolemmal spreading, with stress fibers and nascent myofibrils, whilst type II cells appeared smaller, with more mature myofibril organisation and focal adhesions. Conclusion: Characterization of the redifferentiation capabilities of cultured adult cardiac myocytes in culture, provides an important system for comparing cardiomyocytes differentiating from human stem cells and provides the basis for an in vitro transplantation model to study interaction and communication between primary adult and stem cell-derived cardiomyocytes.

KEYWORDS Adult human cardiomyocyte; Cell isolation; Cell attachment; Laminin; Myofibrillogenesis; Sarcomere; Cadherin


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Cell Sci.Home page
A. J. Engler, C. Carag-Krieger, C. P. Johnson, M. Raab, H.-Y. Tang, D. W. Speicher, J. W. Sanger, J. M. Sanger, and D. E. Discher
Embryonic cardiomyocytes beat best on a matrix with heart-like elasticity: scar-like rigidity inhibits beating
J. Cell Sci., November 15, 2008; 121(22): 3794 - 3802.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
W. A. LaFramboise, D. Scalise, P. Stoodley, S. R. Graner, R. D. Guthrie, J. A. Magovern, and M. J. Becich
Cardiac fibroblasts influence cardiomyocyte phenotype in vitro
Am J Physiol Cell Physiol, May 1, 2007; 292(5): C1799 - C1808.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
J. Butler, A. G. Lee, D. I. Wilson, C. Spalluto, N. A. Hanley, and J. M. East
Phospholamban and sarcolipin are maintained in the endoplasmic reticulum by retrieval from the ER-Golgi intermediate compartment
Cardiovasc Res, April 1, 2007; 74(1): 114 - 123.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
J. Fauconnier, J. T. Lanner, A. Sultan, S.-J. Zhang, A. Katz, J. D. Bruton, and H. Westerblad
Insulin potentiates TRPC3-mediated cation currents in normal but not in insulin-resistant mouse cardiomyocytes
Cardiovasc Res, January 15, 2007; 73(2): 376 - 385.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
J. J. Minguell and A. Erices
Mesenchymal Stem Cells and the Treatment of Cardiac Disease
Experimental Biology and Medicine, January 1, 2006; 231(1): 39 - 49.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
N. Paolocci
Peroxynitrite like Pan?
Cardiovasc Res, August 1, 2005; 67(2): 176 - 178.
[Full Text] [PDF]

Home page
 Toxicol SciHome page
J. C. Davila, G. G. Cezar, M. Thiede, S. Strom, T. Miki, and J. Trosko
Use and Application of Stem Cells in Toxicology
Toxicol. Sci., June 1, 2004; 79(2): 214 - 223.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.